Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0495 USD | +8.32% | 0.00% | -19.51% |
25/04 | North American Morning Briefing : More Tech -2- | DJ |
11/04 | North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge | DJ |
Sales 2021 | - | Sales 2022 | - | Capitalization | 176M 14.71B |
---|---|---|---|---|---|
Net income 2021 | -122M -10.17B | Net income 2022 | -115M -9.59B | EV / Sales 2021 | - |
Net cash position 2021 | 12.15M 1.01B | Net Debt 2022 | 3.2M 267M | EV / Sales 2022 | - |
P/E ratio 2021 |
-2.63
x | P/E ratio 2022 |
-1.23
x | Employees | 66 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99.86% |
Latest transcript on Evelo Biosciences, Inc.
1 day | +8.32% | ||
Current month | +10.00% | ||
1 month | -1.00% | ||
3 months | -23.85% | ||
6 months | -91.89% | ||
Current year | -19.51% |
Managers | Title | Age | Since |
---|---|---|---|
Craig Jalbert
CEO | Chief Executive Officer | 63 | 21/11 |
Andrea Itano
CTO | Chief Tech/Sci/R&D Officer | - | 01/17/01 |
Duncan McHale
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/18/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Jalbert
CEO | Chief Executive Officer | 63 | 21/11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.0495 | +8.32% | 31,190 |
25/24/25 | 0.0457 | +3.39% | 488 |
24/24/24 | 0.0442 | +4.00% | 1,279 |
23/24/23 | 0.0425 | -2.41% | 1,465 |
22/24/22 | 0.0436 | -12.02% | 17,565 |
Delayed Quote OTC Markets, April 27, 2024 at 01:28 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
-19.51% | 940K | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- EVLO Stock